Rare diseases
Investigational molecules
Locations
Gregor-Mendel-Strasse 22, 68526 Oldenburg In Holstein, Germany
Clinical development activities include relapsed or refractory multiple myeloma and broader plasma cell disorders, with attention to patients whose disease has returned or no longer responds to prior treatment.
The research focus in this area centers on therapeutic options for hematologic malignancies arising from abnormal plasma cells.
Heidelberg Pharma AG runs clinical trials in conditions such as Plasma cell myeloma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
